Technetium complexes radiopharmaceuticals

Ajayaghosh A, George SJ, Schenning APHJ (2005) Hydrogen-Bonded Assemblies of Dyes and Extended jr-Conjugated Systems. 258 83-118 Akai S, Kita Y (2007) Recent Advances in Pummerer Reactions. 274-. 35-76 Albert M, Fensterbank L, l.acote E, Malacria M (2006) Tandem Radical Reactions. 264 1-62 Alberto R (2005) New Organometallic Technetium Complexes for Radiopharmaceutical Imaging. 252 1-44... 

Saladino R, Crestini C, Costanzo G, DiMauro E (2005) On the Prebiotic Synthesis of Nucle-obases, Nucleotides, Oligonucleotides, Pre-RNA and Pre-DNA Molecules. 259 29-68 Santos I, Paulo A, Correia JDG (2005) Rhenium and Technetium Complexes Anchored by Phosphines and Scorpionates for Radiopharmaceutical Applications. 252 45-84 Santos M, see Szathmdry E (2005) 259 167-211... 

Acknowledging the important part that 99mTc(V) radiopharmaceuticals are playing in nuclear medicine, advances in their coordination chemistry, as attained by new syntheses and better structural characterization, are discussed with respect to the design of Tc(V) radiotracers. In the light of current interest in making technetium complexes active in vivo, a chapter considering several aspects of reactivity is included. 

Technetium is usually supplied in the form of heptavalent pertechnetate. Consequently, the syntheses of technetium complexes is necessarily accompanied by the reduction of pertechnetate. When concentrated hydrochloric acid is employed as a reductant, tetrachlorooxotechnetate(V) complexes can easily be obtained. A further reduction procedure is required to obtain hexachlorotech-netate(IV). Using these complexes, a number of technetium complexes have been synthesized by ligand substitution. The importance of preparative substitution reactions also increases in the light of the design and preparation of radiopharmaceuticals labelled with 99mTc and 188Re. 

Maecke, H. R. Eisenhut, M. Technetium complexes as radiopharmaceuticals. In Metal-Ligand Interactions in Biological Fluids, Berthon, G., Ed., Dekker New York, 1995. 

Metal-essential radiopharmaceuticals are those whose targeting properties are inherent in the structure and chemistry of the complex itself rather than a biomolecule whose targeting ability is independent of the attachment of the metal. While this class of tracers includes many well-developed technetium complexes, it includes relatively few rhenium complexes. 

Ajayaghosh A, George SJ, Schenning APHJ (2005) Hydrogen-Bonded Assemblies of Dyes and Extended jr-Conjugated Systems. 258 83-118 Alberto R (2005) New Organometallic Technetium Complexes for Radiopharmaceutical Imaging. 252 1-44... 

Alberto R (2005) New Organometallic Technetium Complexes for Radiopharmaceutical imaging. 252 1-44... 

Complexes of technetium in oxidation states ranging from (-1) to (VII) have been prepared chemically and characterized. However, historically only the higher oxidation states (IV), (V) and (VII) have been of major importance in radiopharmaceutical formulations. More recently there has been increased interest in lower oxidation state technetium complexes for medical applications, and the use of ir-acceptor ligands has allowed the preparation of Tc1 complexes which are stable in vivo. The coordination chemistry of technetium has been described in Chapter 42 and recent reviews have been provided by Davison21 and by Schwochau.22 Reviews which relate to medical applications of technetium are given by Jones and Davison,549 Deutsch et al.,20 Deutsch and Barnett,550 Siedel551 and Clarke and Fackler.552 The in vivo chemistry of "mTc chelates has been described by Eckelman and Volkert,553 while the structures of technetium complexes, determined by X-ray diffraction techniques, have been reviewed by Bandoli et ai554... 

---